Verde G, Loli P, Berselli M E, Tagliaferri M, Dallabonzana D, Oppizzi G, Liuzzi A, Chiodini P G, Luccarelli G, Lodrini S
J Endocrinol Invest. 1984 Feb;7(1):51-4. doi: 10.1007/BF03348376.
The case of a young boy bearing a pituitary PRL secreting adenoma (20-30,000 ng/ml) with the unusual association of clinical and endocrinological features of Cushing's disease successfully treated with bromocriptine is described. Brain computed tomography evidenced a huge pituitary adenoma leading to visual field defects and raised intracranial pressure. Due to the very large size of the tumor, which rendered the complete neurosurgical removal unlikely, medical treatment with bromocriptine (10 mg/day) was started. Follow-up for more than six months demonstrated an impressive reduction of tumor size, the lowering of prolactin levels into the normal range, the normalization of visual field, and the regression of both clinical and biochemical signs of hypercortisolism.
本文描述了一名患有垂体泌乳素分泌腺瘤(泌乳素水平为20 - 30,000 ng/ml)的小男孩,其同时伴有库欣病的临床和内分泌特征,经溴隐亭成功治疗。脑部计算机断层扫描显示有一个巨大的垂体腺瘤,导致视野缺损和颅内压升高。由于肿瘤体积非常大,完全通过神经外科手术切除不太可能,因此开始使用溴隐亭(10毫克/天)进行药物治疗。超过六个月的随访显示肿瘤大小显著减小,泌乳素水平降至正常范围,视野恢复正常,高皮质醇血症的临床和生化体征均消退。